A couple of weeks after announcing a seven-figure grant, emocha Mobile Health closed on another $1 million in equity funding.

The Johns Hopkins spinout’s seed round attracted investors including Kapor Capital, the Baltimore Angels, the Propel Baltimore Fund, the Silicon Valley-based Sand Hill Angels and the Blue Jay Syndicate.

The startup’s apps are designed to allow patients to record themselves taking medication. In the case of tuberculosis, it saves resources because health professionals are required to observe patients taking medication. Cofounders Sebastian Seigeur and Morad Elmi have said it also helps improve how patients stick to their treatment, which is known as adherence.

The new funding will help the company as it expands the technology to use in treatment of opioid addiction. A previously announced $1.7 million grant is funding research studies. Seiguer said the company also has plans to launch it commercially.

“Not only do we invest in scalable technology opportunities, we also invest in the talent to turn a startup company into a sustainable organization that will return shareholder value and bring growth to Baltimore City. emocha demonstrates the important and cost-effective role mobile technology increasingly plays in managing complex and high-cost care situations,” stated Christopher College of Columbia-based TCP Venture Capital, which manages the Propel Baltimore Fund.

emocha currently has 11 employees, and is based at Johns Hopkins’ Fast Forward 1812 startup space in East Baltimore.